120 related articles for article (PubMed ID: 2910559)
21. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
[TBL] [Abstract][Full Text] [Related]
22. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen degradation products in pleural effusions.
Raja OG; Casson IF
Br J Dis Chest; 1980 Apr; 74(2):164-8. PubMed ID: 7426355
[TBL] [Abstract][Full Text] [Related]
24. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
25. Pleural fluid pH: diagnostic, therapeutic, and prognostic value.
Houston MC
Am J Surg; 1987 Sep; 154(3):333-7. PubMed ID: 3307471
[TBL] [Abstract][Full Text] [Related]
26. Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients.
Wang Z; Wang C; Huang X; Shen Y; Shen J; Ying K
Biochim Biophys Acta; 2012 Apr; 1824(4):692-700. PubMed ID: 22326748
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
28. Zinc, copper, and iron contents of pleural fluid in benign and neoplastic disease.
Dines DE; Elveback LR; McCall JT
Mayo Clin Proc; 1974 Feb; 49(2):102-6. PubMed ID: 4812820
[No Abstract] [Full Text] [Related]
29. Pleural fluid ferritin concentrations in human disease.
Klockars M; Weber T; Tanner P; Hellström PE; Pettersson T
J Clin Pathol; 1985 Jul; 38(7):818-24. PubMed ID: 4019803
[TBL] [Abstract][Full Text] [Related]
30. Pleural effusion lipoproteins measured by NMR spectroscopy for diagnosis of exudative pleural effusions: a novel tool for pore-size estimation.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4104-12. PubMed ID: 25072840
[TBL] [Abstract][Full Text] [Related]
31. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
32. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
33. Th1 and Th2 cytokine profiles in malignant pleural effusion.
Ghayumi MA; Mojtahedi Z; Fattahi MJ
Iran J Immunol; 2011 Dec; 8(4):195-200. PubMed ID: 22201616
[TBL] [Abstract][Full Text] [Related]
34. Increased soluble Fas ligand concentration in tuberculous pleural effusion.
Wu SH; Chu JJ; Chiang CD
J Formos Med Assoc; 2001 Jan; 100(1):32-4. PubMed ID: 11265257
[TBL] [Abstract][Full Text] [Related]
35. Fibronectin concentrations in pleural and abdominal effusions in dogs and cats.
Hirschberger J; Pusch S
J Vet Intern Med; 1996; 10(5):321-5. PubMed ID: 8884719
[TBL] [Abstract][Full Text] [Related]
36. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.
Zaga T; Makris D; Tsilioni I; Kiropoulos T; Oikonomidi S; Damianos A; Gourgoulianis KI
Monaldi Arch Chest Dis; 2011 Sep; 75(3):167-71. PubMed ID: 22428219
[TBL] [Abstract][Full Text] [Related]
39. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor in pleural fluid.
Cheng D; Rodriguez RM; Perkett EA; Rogers J; Bienvenu G; Lappalainen U; Light RW
Chest; 1999 Sep; 116(3):760-5. PubMed ID: 10492284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
